ID | PEPTIDE SEQUENCE | PEPTIDE NAME | LENGTH | CHIRALITY | LINEAR/CYCLIC | SOURCE | CATEGORY | N TERMINAL MODIFICATION | C TERMINAL MODIFICATION | CHEMICAL MODIFICATION | CARGO | PUBMED ID |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2001 | rrrrrrrrrcqcrrkn | R9-GO-203 | 16 | D | Linear | Synthetic | Cationic | Free | Free | NA | Small molecule drug (Taxol and doxorubicin) | 23114713 |
2002 | RRRRRRRGGIYLATALAKWALKQGF | P7-4 | 25 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-27 | 23262194 |
2003 | IYLATALAKWALKQGFGGRRRRRRR | P7-5 | 25 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-27 | 23262194 |
2004 | RRRRRRRGGIYLATALAKWALKQ | P7-6 | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-26 | 23262194 |
2005 | IYLATALAKWALKQGGRRRRRRR | P7-7 | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-26 | 23262194 |
2006 | RRRRRRRGGKLAKLAKKLAKLAK | R7-KLA | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] | 23262194 |
2007 | KLAKLAKKLAKLAKGGRRRRRRR | KLA-R7 | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] | 23262194 |
2008 | RWRWRWRW | (RW)4 | 8 | L | Linear | Synthetic | Cationic | Free | Free | Drug conjugated with peptide through linker | Small molecule drug (Doxorubicin) | 23301519 |
2010 | YGRKKRRQRRR | Tat-AIE dots | 11 | L | Linear | Protein derived | Amphipathic | Free | Free | NA | TPETPAFN and TPAFN | 23359649 |
2011 | KKALLAHALHLLALLALHLAHALKKA | LAH4-L1 | 26 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | Nucleic acid (siRNA) | 23436406 |
2012 | RRRRRRRR | R9-GFP | 8 | L | Linear | Synthetic | Cationic | Free | Free | NA | Protein (eGFP) | 23497160 |
2015 | KAFAKLAARLYRKALARQLGVAA | KAFAK | 23 | L | Linear | Synthetic | NA | Free | Free | NA | Fluorophore (FITC) | 23041412 |
2016 | GSRVQIRCRFRNSTR | HSV-1 glycoprotein C gene (gC)--Crystallins | 15 | L | Linear | Synthetic | NA | Free | Free | NA | Protein (Human B-Crystallin) | 23150610 |
2017 | GRKKRRQRRRPQ | HIV-1 TAT peptide--Crystallins | 12 | L | Linear | Protein derived | NA | Free | Free | NA | Protein (Human B-Crystallin) | 23150610 |
2018 | CRNGRGPDC | iNGR | 9 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
2019 | CNGRC | NGR | 5 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
2020 | CRGDC | RGD | 5 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
2021 | CRGDKGDPC | iRGD | 9 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
2022 | NYRWRCKNQN | ECP(32-41) | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC), Protein (eGFP) and Peptide (KLA) | 23469189 |
2023 | NYQRRCKNQN | EDN(32-41) | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2024 | NYQWRCKNQN | ECP(32-41)R3Q | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2025 | NYRRRCKNQN | ECP(32-41)W4R | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2026 | YRWRCKNQN | ECP(33-41) | 9 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2027 | NYRWRCKNQ | ECP(32-40) | 9 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2028 | YRWRCKNQ | ECP(33-40) | 8 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2029 | NYRWRCKN | ECP(32-39) | 8 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2030 | RWRCKNQN | ECP(34-41) | 8 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2031 | NYRWRCK | ECP(32-38) | 7 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2032 | GRKKRRQRRRP | TAT(47-57) | 11 | L | Linear | Protein derived | Amphipathic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2033 | KLAKLAKKLAKLAK | KLA | 14 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
2034 | KLAKLAKKLAKLAKGRKKRRQRRRP | KLA-TAT(47-57) | 25 | L | Linear | Chimeric | Cationic | Free | Free | NA | Peptide (KLA) | 23469189 |
2035 | KLAKLAKKLAKLAKNYRWRCKNQN | KLA-ECP(32-41) | 24 | L | Linear | Chimeric | Cationic | Free | Free | NA | Peptide (KLA) | 23469189 |
2044 | RKKRRQRRRGC | Tat-Cys | 11 | L | Linear | Protein derived | Cationic | Free | Amidation | NA | Fluorophore (TMR-5(6)C2- maleimide) | 23322746 |
2045 | RPARPAR | PA 1 | 7 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | Fluorophore (Rhodamine) | 23349939 |
2048 | RPARPAR | PA 4 | 7 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | DSP-PEG2000 and Fluorophore (Rhodamine) | 23349939 |
2049 | RPARPAR | PA 5 | 7 | L | Linear | Synthetic | Amphipathic | Free | Amidation | NA | DSP-PEG2000 and Fluorophore (Rhodamine) | 23349939 |
2051 | RKKWFW | PAF26 | 6 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (TMR) | 23349973 |
2052 | AAAWFW | PAF95 | 6 | L | Linear | Synthetic | NA | Free | Free | NA | Fluorophore (TMR) | 23349973 |
2053 | RKKAAA | PAF96 | 6 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (TMR) | 23349973 |
2061 | GGRRARRRRRR | CTP | 11 | L | Linear | Protein derived | NA | Free | Free | NA | Peptide (HBcAg18 27-Tapasin) | 23299079 |
2062 | RRRRRRRRRRR | R11 | 11 | L | Linear | Synthetic | NA | Free | Free | Histidine tagged | Nanoparticles [Nanostructured lipid carriers (NLC) and Ibuprofen (Ibu)] | 23187866 |
2063 | YKALRISRKLAK | YKA peptide | 12 | L | Linear | Synthetic | NA | Free | Free | Histidine tagged | Nanoparticles [Nanostructured lipid carriers (NLC) and Ibuprofen (Ibu)] | 23187866 |
2064 | KETWWETWWTEWSQPKKKRKVC | FP-lipo | 22 | L | Linear | Synthetic | Cationic | Free | Free | NA | Nanoparticle (Liposomes and folic acid) | 23515421 |
2065 | RRRRR | R5 | 5 | L | Linear | Synthetic | Cationic | Free | Free | NA | Nucleic acid (pDNA) | 23534410 |
2066 | RRRRRRR | R7 | 7 | L | Linear | Synthetic | Cationic | Free | Free | NA | Nucleic acid (pDNA) | 23534410 |
2067 | RRRRRRRRR | R9 | 9 | L | Linear | Synthetic | Cationic | Free | Free | NA | Nucleic acid (pDNA) | 23534410 |
2068 | RRRRRRRRRRR | R11 | 11 | L | Linear | Synthetic | Cationic | Free | Free | NA | Nucleic acid (pDNA) | 23534410 |
2069 | CVSRRRRRRGGRRRR | LMWP | 15 | L | Linear | Synthetic | Cationic | Free | Free | NA | Nanoparticles and Fluoriophore (coumarin-6) | 23350619 |
2070 | EEEEEEEEEE-PLGLAG-VSRRRRRRGGRRRR | ALWMP | 24 | L | Linear | Synthetic | NA | Free | Free | Linker (PLGLAG) | Nanoparticles and Fluoriophore (coumarin-6) | 23350619 |
2072 | KFFKFFKFFK | CPP-PNA | 10 | L | Linear | Synthetic | NA | Free | Conjugation with nucleic acid | Nucleic acid is attached via an ethylene glyol linker | PNA | 23305655 |